Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor

Molecular Pharmacology

Volumn 74, Issue 3, 2008, Pages 585-594

  Barak, Larry S ^a   Salahpour, Ali ^a   Zhang, Xiaodong ^a   Masri, Bernard ^a   Sotnikova, Tatyana D ^a   Ramsey, Amy J ^a   Violin, Jonathan D ^a,b   Lefkowitz, Robert J ^a,b   Caron, Marc G ^a,b   Gainetdinov, Raul R ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; ANTIPORTER; ASPARAGINE; BETA ARRESTIN; BIOGENIC AMINE; CYCLIC AMP; DEXAMPHETAMINE; EPAC PROTEIN; G PROTEIN COUPLED RECEPTOR; LIGAND; METHAMPHETAMINE; NEUROTRANSMITTER; OCTOPAMINE; PHENTERMINE; RECEPTOR PROTEIN; TRACE AMINE ASSOCIATED RECEPTOR 1; TRYPTAMINE; TYRAMINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CAMP BRET BIOSENSOR; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

BIOSENSING TECHNIQUES; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CYCLIC AMP; DEXTROAMPHETAMINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; PHENETHYLAMINES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 50449102062     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.048884     Document Type: Article

References (37)

1. Barak LS, Ferguson SS, Zhang J, and Caron MG (1997) A β-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem 272:27497-27500.
2. Barak LS, Oakley RH, Laporte SA, and Caron MG (2001) Constitutive arrestinmediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci U S A 98:93-98.
3. Berry MD (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90:257-271.
4. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, et al. (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 98:8966-8971.
5. Boulton AA (1980) Trace amines and mental disorders. Can J Neurol Sci 7:261-263.
6. Branchek TA and Blackburn TP (2003) Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3:90-97.
7. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, et al. (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181-1188.
8. DiPilato LM, Cheng X, and Zhang J (2004) Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci U S A 101:16513-16518.
9. Fahn S (2003) Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 991:1-14.
10. Grandy DK (2007) Trace amine-associated receptor 1-Family archetype or iconoclast? Pharmacol Ther 116:355-390.
11. Hamdan FF, Audet M, Garneau P, Pelletier J, and Bouvier M (2005) Highthroughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay. J Biomol Screen 10:463-475.
12. Holz GG, Kang G, Harbeck M, Roe MW, and Chepurny OG (2006) Cell physiology of cAMP sensor Epac. J Physiol 577:5-15.
13. Hornykiewicz O (2002) L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids 23:65-70.
14. Jiang LI, Collins J, Davis R, Lin KM, DeCamp D, Roach T, Hsueh R, Rebres RA, Ross EM, Taussig R, et al. (2007) Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J Biol Chem 282:10576-10584.
15. Jones SR, Gainetdinov RR, Wightman RM, and Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986.
16. Kim KA and von Zastrow M (2001) Old drugs learn new tricks: insights from mammalian trace amine receptors. Mol Pharmacol 60:1165-1167.
17. Kim KM, Gainetdinov RR, Laporte SA, Caron MG, and Barak LS (2005) G proteincoupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-arrestin complex. A case of autoreceptor regulation. J Biol Chem 280:12774-12780.
18. Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, and Caron MG (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and -arrestins. J Biol Chem 276:37409-37414.
19. Liberles SD and Buck LB (2006) A second class of chemosensory receptors in the olfactory epithelium. Nature 442:645-650.
20. Lindemann L and Hoener MC (2005) A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 26:274-281.
21. Mercuri NB and Bernardi G (2005) The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci 26:341-344.
22. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, and Madras BK (2005) Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313:983-994.
23. Ponsioen B, Zhao J, Riedl J, Zwartkruis F, van der Krogt G, Zaccolo M, Moolenaar WH, Bos JL, and Jalink K (2004) Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep 5:1176-1180.
24. Premont RT, Gainetdinov RR, and Caron MG (2001) Following the trace of elusive amines. Proc Natl Acad Sci U S A 98:9474-9475.
25. Rands E, Candelore MR, Cheung AH, Hill WS, Strader CD, and Dixon RA (1990) Mutational analysis of -adrenergic receptor glycosylation. J Biol Chem 265:10759-10764.
26. Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, and Grandy DK (2007) Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. J Pharmacol Exp Ther 321:178-186.
27. Sadeghi HM, Innamorati G, and Birnbaumer M (1997) Maturation of receptor proteins in eukaryotic expression systems. J Recept Signal Transduct Res 17:433-445.
28. Saito H, Kubota M, Roberts RW, Chi Q, and Matsunami H (2004) RTP family members induce functional expression of mammalian odorant receptors. Cell 119:679-691.
29. Salomon Y, Londos C, and Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548.
30. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, et al. (2004) 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638-642.
31. Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, and Gainetdinov RR (2004) Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine. J Neurochem 91:362-373.
32. Violin JD, DiPilato LM, Yildirim N, Elston TC, Zhang J, and Lefkowitz RJ (2008) 2-Adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real-time camp dynamics. J Biol Chem 283:2949-2961.
33. Wainscott DB, Little SP, Yin T, Tu Y, Rocco VP, He JX, and Nelson DL (2007) Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. J Pharmacol Exp Ther 320:475-485.
34. Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, and Gerald CP (2007) The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6:628-639.
35. Xie Z and Miller GM (2007) Trace amine-associated receptor 1 is a modulator of the dopamine transporter. J Pharmacol Exp Ther 321:128-136.
36. Xie Z, Westmoreland SV, Bahn ME, Chen GL, Yang H, Vallender EJ, Yao WD, Madras BK, and Miller GM (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321:116-127.
37. Zhuang H and Matsunami H (2007) Synergism of accessory factors in functional expression of mammalian odorant receptors. J Biol Chem 282:15284-15293.